CHICAGO—Researchers said a drug being developed by Mylan Pharmaceuticals Inc. proved comparable to Roche Holding AG’s Herceptin in a clinical trial, a …
Xylogenics has performed over 6,000 commercial process model analyses. This combined with our unique IT and analytics platform allows us to model commercial fermentation processes with tremendous accuracy and predictability.
Xylogenics has a combined 100+ years of experience in genetics, metabolic engineering, physiology, and molecular biology, with 75+ years of experience in the yeast, Saccharomyces cerevisiae. This experience is harnessed to design, construct, and validate novel organisms that enable more efficient and productive bio-based chemical synthesis.
Xylogenics team has rare experience shepherding enhanced yeast through
the commercial scale-up process.
This process includes yeast production optimization and commercial scale implementation of novel fermentation systems.
Our team is made up of home brewers, thinkers, innovators, farmers, scientists, problem solvers, and business development leaders. These traits of the Xylogenics team are intensely focused on delivering product innovations that are safe, scalable, and highly valuable to bio-based chemical producers.
The 2016 National Advanced Biofuels Conference & Expo took place in Milwaukee, Wisconsin, this week, hosting a number of panels …